3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector

RxCUI
1860167
RxNorm name
3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector
Display name
3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector
Full name
3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
208583Xultophy 100/3.6insulin degludec and liraglutide351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Xultophy 100/3.6INSULIN DEGLUDEC AND LIRAGLUTIDENovo Nordisk21335fe4-d395-4501-ac2a-2f20d7520da92025-10-14Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1860167

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
21335fe4-d395-4501-ac2a-2f20d7520da9insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML in 3 ML Pen Injector [PSN] · 3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector [SCD] · insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML per 3 ML Pen Injector [SY]314These highlights do not include all the information needed to use XULTOPHY 100/3.6 safely and effectively. See full prescribing information for XULTOPHY 100/3.6 . XULTOPHY ® 100/3.6 (insulin degludec and liraglutide) injection, for subcutaneous use Initial U.S. Approval: 201620251014